ArticleNano letters2023
Quantum Plexcitonic Sensing.
Article in Nano letters, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Spectral Super-Resolution Colloidal SERS Spectroscopy for Multiplexed Detection of Protein Biomarkers.Nano letters · 2026Article
- Quantum vibropolaritonic sensing.Science advances · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
While fundamental to quantum sensing, quantum state control has been traditionally limited to extreme conditions. This restricts the impact of the practical implementation of quantum sensing on a broad range of physical measurements. Plexcitons, however, provide a promising path under ambient conditions toward quantum state control and thus quantum sensing, owing to their origin from strong plasmon-exciton coupling. Herein, we harness plexcitons to demonstrate quantum plexcitonic sensing by strongly coupling excitonic particles to a plasmonic hyperbolic metasurface. As compared to classical sensing in the weak-coupling regime, our model of quantum plexcitonic sensing performs at a level that is ∼40 times more sensitive. Noise-modulated sensitivity studies reinforce the quantum advantage over classical sensing, featuring better sensitivity, smaller sensitivity uncertainty, and higher resilience against optical noise. The successful demonstration of quantum plexcitonic sensing opens the door for a variety of physical, chemical, and biological measurements by leveraging strongly coupled plasmon-exciton systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.